Contrast media are very important for the imaging and contrasting of body structure and organs and therefore pilots to easy discovery of any dysfunctionality in the body of human being. Rising frequency of diseases and increasing median age of the population along with predominance of chronic problems includes cancer and cardiac diseases are the main things that are impel the development of the contrast agent market. Developing technology has also lead to superior diagnostic and imaging so pouring the contrast agent market. Increasing technological development in ultrasound divergent agent technology is also expected to contribute to the enlargement of Contrast Media Contrast Agents Market.
How big is the Global Contrast Agents Market?
The Global Contrast Agents Market is expected to be around US$ 6.80 billion by 2028 and will grow at a CAGR of more than 4% in the given forecast period.
The major driving factors of Global Contrast Agents Market are as follows:
• Growing number of private and public diagnostic centers.
• Increasing approvals for contrast agents.
The restraining factors of Global Contrast Agents Market are as follows:
• Side Effects related with contrast agents.
The Contrast Agents Market is segmented on the lines of its product, route of administration, medical procedure, indication, application and regional. Based on product segmentation it covers gadolinium-based contrast media, iodinated contrast media and barium-based contrast media. Iodinated contrast media is further segmented into high-osmolar contrast media (HOCM) and low-osmolar contrast media (LOCM). Under administration segmentation it covers urethral, oral, rectal and injection. Injection is further segmented into intra-arterial and intravenous. Medical procedure is classified into catheterization laboratory (cath lab), ultrasound, X-ray, computed tomography (CT) and magnetic resonance imaging (MRI). Indication segmentation is classified into oncology (tumor detection), neurological disorders, cardiovascular disorders, nephrological disorders, gastrointestinal disorders and musculoskeletal anomalies. Based on application segmentation it covers radiology, interventional cardiology and interventional radiology. The contrast media contrast agent’s market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Contrast Agents Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for contrast media contrast agents.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Contrast Agents Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Bayer Healthcare Pharmaceuticals (Germany), Medrad Inc., SupertechInc, Lantheus Medical, ACIST Medical Systems, AMAG Pharmaceuticals, Inc, Canadian Imaging, NanoScan Imaging, Pinyons Medical Technology, TargesonInc, Beekley Medical, Mallinckrodt Pharmaceuticals, Nova Biomedical, NycomedAmersham, Daiichi, Covidien (Ireland), GE Healthcare (U.K.), Bracco Diagnostic Inc. (Italy), and Guerbet Group (France). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Contrast Agents Market has been segmented as below:
By Products Analysis
• Gadolinium-based contrast media
• Iodinated contrast media
• High-osmolar contrast media (HOCM)
• Low-osmolar contrast media (LOCM)
• Barium-based contrast media
By Route of Administration Analysis
• Urethral
• Oral
• Rectal
• Injection
o Intra-arterial
o Intravenous
By Medical procedure Analysis
• Catheterization laboratory (cath lab)
• Ultrasound
• X-ray
• Computed tomography (CT)
• Magnetic resonance imaging (MRI)
By Indication Analysis
• Oncology (tumor detection)
• Neurological disorders
• Cardiovascular disorders
• Nephrological disorders
• Gastrointestinal disorders
• Musculoskeletal anomalies
By Application Analysis
• Radiology
• Interventional cardiology
• Interventional radiology
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Contrast Agents Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of contrast media contrast agents data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Clinical Alarm Management Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Insights From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions
3 Executive Summary
3.1 Introduction
3.2 Conclusion
4 Premium Insights
4.1 Contrast Media Market Overview
4.2 Contrast Media Market, By Type and Route of Administration (2018)
4.3 Geographic Snapshot: Contrast Media Market
4.4 Global Contrast Media Market, By Indication (2018 vs 2024)
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Large Number of Approvals for Contrast Agents
5.2.1.2 Increasing Number of Public and Private Diagnostic Centers
5.2.2 Restraint
5.2.2.1 Side Effects and Allergic Reactions Associated With Contrast Agents
5.2.3 Opportunity
5.2.3.1 Increasing Number of Research and Funding Activities for Contrast Agents
5.2.4 Challenges
5.2.4.1 Development of Gamma and Neutron Imaging Solutions
5.2.4.2 Need for Highly Skilled Professionals
6 Pipeline Assessment
6.1 Introduction
6.1.1 Clinical Trials Using Contrast Media
6.1.2 Product Pipeline
7 Global Contrast Media Market, By Type
7.1 Introduction
7.2 Iodinated Contrasts Media
7.3 Gadolinium-Based Contrasts Media
7.4 Microbubble Contrasts Media
7.5 Barium- Based Contrasts Media
8 Global Contrast Media Market, By Medical Procedure
8.1 Introduction
8.2 X-Ray/CT
8.3 MRI
8.4 Ultrasound
9 Global Contrast Media Market, By Route of Administration
9.1 Introduction
9.2 Injectable Contrasts Media
9.3 Oral Contrasts Media
9.4 Rectal Contrasts Media
9.5 Urethral Contrasts Media
10 Global Contrast Media Market, By Indication
10.1 Introduction
10.2 Cardiovascular Disorders
10.3 Oncology
10.4 Gastrointestinal Disorders
10.5 Neurological Disorders
10.6 Nephrological Disorders
10.7 Musculoskeletal Disorders
11 Global Contrast Media Market, By Application
11.1 Introduction
11.2 Radiology
11.3 Interventional Cardiology
11.4 Interventional Radiology
12 Contrast Media Market, By Region
12.1 Introduction
12.2 North America
12.2.1 U.S.
12.2.1.1 Increasing Number of Diagnostic Imaging Tests and Centers
12.2.1.2 Rising Aging Population, Rising Prevalence of Chronic Diseases
12.2.1.3 Prevalence of Alzheimer’s Disease and Other Dementias
12.2.2 Canada
12.2.2.1 Rising Aging Population, High Incidence of Cancer, Cvd, and Diabetes
12.2.2.2 Increasing MRI and CT Examinations
12.2.2.3 Increasing Research Activities
12.3 Europe
12.3.1 Europe 5
12.3.1.1 Increase in Investments By Market Players
12.3.1.2 Increasing Incidence and Prevalence of Cancer
12.3.1.3 U.K.: Lack of Sufficient Instruments
12.3.1.4 Conferences/Meetings/Symposiums/Workshops in Europe
12.3.2 RoE
12.3.2.1 Increase Focus of Market Players on RoE Countries
12.4 Asia-Pacific
12.4.1 Rise in Aging Population and Cancer Incidence
12.4.2 Expansion of International Players in China and India
12.4.3 Increasing R&D Investments in China
12.4.4 Favorable Regulatory Changes in New Zealand and Australia
12.4.5 Increasing Research Activities in Asia-Pacific
12.5 Rest of the World
12.5.1 Latin America
12.5.2 The Middle East
12.5.3 Africa
13 Competitive Landscape
13.1 Overview
13.2 Market Share Analysis
13.2.1 Bayer Healthcare
13.2.2 GE Healthcare
13.3 Competitive Scenario
13.3.1 Market Developments (Product Approvals)
13.3.2 Agreements, Collaborations, Contracts, and Partnerships
13.3.3 Expansions
13.3.4 Other Strategies
14 Company Profiles
14.1 Introduction
14.2 GE Healthcare
14.3 Bayer AG
14.4 Bracco Imaging S.P.A.
14.5 Guerbet Group
14.6 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
14.7 Nanopet Pharma GmbH
14.8 CMC Contrast AB
14.9 Daiichi Sankyo
14.10 Subhra Pharma Private Limited
14.11 Spago Nanomedical AB
The Contrast Agents Market has been segmented as below:
By Products Analysis
• Gadolinium-based contrast media
• Iodinated contrast media
• High-osmolar contrast media (HOCM)
• Low-osmolar contrast media (LOCM)
• Barium-based contrast media
By Route of Administration Analysis
• Urethral
• Oral
• Rectal
• Injection
o Intra-arterial
o Intravenous
By Medical procedure Analysis
• Catheterization laboratory (cath lab)
• Ultrasound
• X-ray
• Computed tomography (CT)
• Magnetic resonance imaging (MRI)
By Indication Analysis
• Oncology (tumor detection)
• Neurological disorders
• Cardiovascular disorders
• Nephrological disorders
• Gastrointestinal disorders
• Musculoskeletal anomalies
By Application Analysis
• Radiology
• Interventional cardiology
• Interventional radiology
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
SUBSCRIBE TO OUR NEWSLETTERS
